Chicago, Illinois-based Mondelez International, Inc (MDLZ) manufactures, markets, and sells snack food and beverage products. Valued at $87.4 billion by market cap, the company offers a wide range of products such as biscuits, baked snacks, chocolates, gums, candies, cheese, and powdered beverages under brands like Oreo, Ritz, LU, CLIF Bar, Tate’s Bake Shop, Cadbury Dairy Milk, Milka, and Toblerone. 

Companies worth $10 billion or more are generally described as “large-cap stocks,” and MDLZ perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the confectioners industry. 

Despite its notable strength, MDLZ slipped 11.9% from its 52-week high of $76.06, achieved on Sep. 10, 2024. Over the past three months, MDLZ stock gained 1.9%, underperforming the Consumer Staples Select Sector SPDR Fund’s (XLP) marginal losses during the same time frame.

In the longer term, shares of MDLZ rose 12.2% on a YTD basis, outperforming XLP’s 5.3% gains over the same time frame. However, MDLZ fell marginally over the past 52 weeks, underperforming XLP’s 7.1% returns over the last year.

To confirm the bullish trend, MDLZ is trading above its 50-day moving average since early February, with some fluctuations. The stock has been trading above its 200-day moving average since early March, experiencing some fluctuations. 

MDLZ's struggles stem from currency issues and the expiration of a short-term distribution deal linked to its gum business sale.

On Apr. 29, MDLZ shares closed up marginally after reporting its Q1 results. Its adjusted EPS of $0.74 exceeded Wall Street expectations of $0.65. The company’s revenue was $9.31 billion, falling short of Wall Street forecasts of $9.33 billion.

MDLZ’s rival, The Hershey Company (HSY) shares lagged behind the stock, with a 3.7% loss on a YTD basis and 17% decline over the past 52 weeks.

Wall Street analysts are moderately bullish on MDLZ’s prospects. The stock has a consensus “Moderate Buy” rating from the 25 analysts covering it, and the mean price target of $71.71 suggests a potential upside of 7% from current price levels.